[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CH584755A5 - - Google Patents

Info

Publication number
CH584755A5
CH584755A5 CH872872A CH872872A CH584755A5 CH 584755 A5 CH584755 A5 CH 584755A5 CH 872872 A CH872872 A CH 872872A CH 872872 A CH872872 A CH 872872A CH 584755 A5 CH584755 A5 CH 584755A5
Authority
CH
Switzerland
Application number
CH872872A
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of CH584755A5 publication Critical patent/CH584755A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH872872A 1971-06-12 1972-06-12 CH584755A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2765371A GB1395907A (en) 1971-06-12 1971-06-12 Antibiotics

Publications (1)

Publication Number Publication Date
CH584755A5 true CH584755A5 (xx) 1977-02-15

Family

ID=10263082

Family Applications (1)

Application Number Title Priority Date Filing Date
CH872872A CH584755A5 (xx) 1971-06-12 1972-06-12

Country Status (6)

Country Link
US (1) US4289703A (xx)
JP (2) JPS548753B1 (xx)
BE (1) BE893376Q (xx)
CH (1) CH584755A5 (xx)
DE (1) DE2227739C2 (xx)
GB (1) GB1395907A (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565083A (en) * 1976-02-20 1980-04-16 Beecham Group Ltd Pseudomonic acid amides
GB1587058A (en) * 1976-06-15 1981-03-25 Beecham Group Ltd Oxiranylmethyltetrahydropyran derivatives
GB1577730A (en) * 1976-10-23 1980-10-29 Beecham Group Ltd Treatment of infections with pseudomonicacid salts or esters thereof
US4206224A (en) * 1976-10-23 1980-06-03 Beecham Group Limited Treatment of infections
CA1103264A (en) * 1977-09-30 1981-06-16 Norman H. Rogers Purification of pseudomonic acid
EP0003069B1 (en) * 1977-11-01 1981-05-20 Beecham Group Plc Pseudomonic acid c, pharmaceutically acceptable salts or esters thereof, processes for their preparation and pharmaceutical or veterinary compositions containing them
GB2009154B (en) * 1977-11-10 1982-06-23 Beecham Group Ltd Antibacterial compounds
IL56003A0 (en) * 1977-12-03 1979-01-31 Beecham Group Ltd Novel thiol esters of monic acid, their preparation and pharmaceutical compositions containing them
EP0004412A1 (en) * 1978-01-21 1979-10-03 GKN Transmissions Limited Continuously variable transmission mechanisms
CA1115699A (en) * 1978-05-20 1982-01-05 Alan D. Curzons Lithium pseudomonate and its preparation
DE3066424D1 (en) * 1979-11-10 1984-03-08 Beecham Group Plc Antibacterial derivatives of monic acid, processes for their preparation and compositions containing them
EP0042233A1 (en) * 1980-06-14 1981-12-23 Beecham Group Plc 13-oxo-monic acid and its salts and esters, process for their production, and compositions containing them
US4436751A (en) 1980-12-31 1984-03-13 Beecham Group Limited Nitrobenzyl monates antibacterial compounds
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GB8313035D0 (en) * 1983-05-12 1983-06-15 Beecham Group Plc Compound
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
US5594026A (en) * 1990-12-11 1997-01-14 Smithkline Beecham Group P.L.C. Polymorphs of crystalline mupirocin
GB9026873D0 (en) * 1990-12-11 1991-01-30 Beecham Group Plc Novel compounds
CN1203184C (zh) 1999-02-03 2005-05-25 拜奥盖尔药厂有限公司 经微生物学方法制备假单胞菌酸a抗生素的方法
HUP0105286A3 (en) 1999-02-03 2003-03-28 Biogal Gyogyszergyar Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth
ES2228294T1 (es) * 2001-06-21 2005-04-16 Biogal Gyogyszergyar Rt. Proceso de fermentacion metabolico controlado para la produccion de acido pseudomonico.
DE20220885U1 (de) * 2001-12-28 2004-06-24 BIOGAL Gyógyszergyár Rt. Kristallines und amorphes Mupirocin-Calcium
KR20060123772A (ko) 2004-06-01 2006-12-04 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 약물의 비결정형의 제조 방법
AU2006215708B2 (en) * 2005-02-21 2011-01-27 Syngen Biotech Co., Ltd Purification of mupirocin
GB2441328A (en) * 2006-08-30 2008-03-05 Alpharma Aps A method for obtaining mupirocin calcium
CN116018342A (zh) * 2020-08-25 2023-04-25 杭州中美华东制药有限公司 一种莫匹罗星的提取方法

Also Published As

Publication number Publication date
GB1395907A (en) 1975-05-29
US4289703A (en) 1981-09-15
DE2227739A1 (de) 1973-01-04
JPS5495796A (en) 1979-07-28
BE893376Q (fr) 1982-10-01
JPS548753B1 (xx) 1979-04-18
JPS5638119B2 (xx) 1981-09-04
DE2227739C2 (de) 1982-07-29

Similar Documents

Publication Publication Date Title
JPS5638119B2 (xx)
AR196074A1 (xx)
AU2691671A (xx)
AU2742671A (xx)
AU2952271A (xx)
AU2941471A (xx)
AU2894671A (xx)
AU3005371A (xx)
AU2837671A (xx)
AU2907471A (xx)
AU2755871A (xx)
AU2880771A (xx)
AU2836771A (xx)
AU2726271A (xx)
AU2875571A (xx)
AU2885171A (xx)
AU2724971A (xx)
AU2740271A (xx)
AU2927871A (xx)
AU2930871A (xx)
AU2938071A (xx)
AU2706571A (xx)
AU2684171A (xx)
AU2854371A (xx)
AU2963771A (xx)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased